Nephrology @ Point of Care | |
Ivabradine, Heart Failure and Chronic Kidney Disease: | |
LucaDi Lullo1  | |
关键词: Beta-blockers; Heart failure; Ivabradine; Ventricular remodeling; | |
DOI : 10.5301/poc.5000190 | |
学科分类:医学(综合) | |
来源: Sage Journals | |
![]() |
【 摘 要 】
The incidence and prevalence of congestive heart failure are actually increasing worldwide, especially in Western countries. In Europe and the United States, congestive heart failure represents a disabling clinical disease, accountable for increased hospitalization and health care costs. European guidelines have underlined the importance of pharmacological treatment to improve both patients' outcomes and quality of life. The latest clinical trials to evaluate ivabradine's efficacy have underlined its usefulness as a stand-alone medication and in combination with conventional congestive heart failure therapy, including in chronic kidney disease patients.
【 授权许可】
CC BY
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO201901216854385ZK.pdf | 195KB | ![]() |